A recent guidance update from the U.S. Food and Drug Administration (FDA) on pyrogen and endotoxins testing represents a missed opportunity to meaningfully advance alternatives to horseshoe-crab-blood ...
The U.S. Pharmacopeia has approved synthetic alternatives to horseshoe crab blood for bacterial endotoxin testing, a regulatory shift that could reduce the pharmaceutical industry’s reliance on ...
The majority of recent empirical papers in operations management (OM) employ observational data to investigate the causal effects of a treatment, such as program or policy adoption. However, as ...
The DNA synthesis market offers significant growth opportunities driven by tailored therapies, DNA-based research, and diagnostics. Key market prospects include advancements in enzymatic synthesis, ...
Despite these advances, the synthesis of DNA nanostructures has remained a largely manual and time-consuming process. Traditional approaches often require the precise mixing of hundreds of unique DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results